DOXEPIN HYDROCHLORIDE

Product NDC
70518-2984
11-digit product format
705182984
Labeler code
70518
Product ID
70518-2984_b8674b6b-691b-7196-e053-2a95a90ac754
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DOXEPIN HYDROCHLORIDE
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA213063
Marketing category
ANDA
Marketing start
2021-01-08
Marketing end
0000-00-00
Substance
DOXEPIN HYDROCHLORIDE
Active strength
100 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2984-02023-03-14C16284748780-1f386c649-d3a5-0266-e053-dadaa90a7c1ac2d8f9c4-d364-46de-b613-d0bdf4b7aba3
70518-2984-02023-01-30C16284748780-1f386c649-d3a5-0266-e053-dadaa90a7c1ac2d8f9c4-d364-46de-b613-d0bdf4b7aba3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2984-07051829840030 CAPSULE in 1 BLISTER PACK (70518-2984-0) 30 capsule2021-01-080000-00-00NoNoCurrent